TREATMENT OF DIABETES, OBESITY AND ASSESSMENT OF END ORGAN DAMAGE (KIDNEY AND LIVER/INTESTINE)
30.06.20
Join us for this two-day symposium on the assessment and treatment of end-organ damage in kidney and metabolic disease focusing on new markers of interest, ultrasound and scanners and laboratory equipments of interest in kidney, liver and diabetes management and assessment. Furthermore, participants will gain insight in gut peptide biology and clinical implications for diabetic and obese patients.
The symposium is intended for basic and clinical researchers, PhD students, medical students, industry trial planners, industry directors and industry technical staff working within any field of diabetes.